Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced a peer-reviewed publication about its generative AI model in Nature Communications. The paper ...
The global liquid biopsy market size was valued at USD 10.99 billion in 2024 and is projected to reach from USD 12.23 billion ...
Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Clinical Test for Lung for liquid biopsy samples. Aspyre Clinical Test for Lung analyzes all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback